Production (Stage)
Eupraxia Pharmaceuticals Inc.
EPRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.06% | 282.15% | -62.85% | -35.07% | 85.65% |
| Total Receivables | 4.19% | 116.15% | -31.77% | -7.18% | -12.28% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -17.46% | -1.41% | 6.49% | 647.98% | -47.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.93% | 248.20% | -59.67% | -32.28% | 82.88% |
|
|
|||||
| Total Current Assets | -16.93% | 248.20% | -59.67% | -32.28% | 82.88% |
| Net Property, Plant & Equipment | 28.62% | -6.92% | 2.47% | 7.38% | -9.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.74% | 339.13% | 300.00% | -17.86% | -18.84% |
| Total Assets | -16.34% | 237.12% | -58.50% | -31.83% | 80.77% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -30.18% | 32.54% | 16.67% | -50.09% | 0.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -26.56% | -8.76% | -98.30% | -51.61% | -8.56% |
| Total Finance Division Other Current Liabilities | 118.36% | -7.17% | -99.56% | -0.78% | 0.31% |
| Total Other Current Liabilities | 118.36% | -7.17% | -99.56% | -0.78% | 0.31% |
| Total Current Liabilities | -29.11% | 30.80% | -79.55% | -37.38% | -4.36% |
|
|
|||||
| Total Current Liabilities | -29.11% | 30.80% | -79.55% | -37.38% | -4.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -59.14% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -29.11% | 30.01% | -79.49% | -37.19% | -4.36% |
|
|
|||||
| Common Stock & APIC | 1.41% | 0.78% | 0.37% | 1.10% | 21.19% |
| Retained Earnings | -5.16% | -6.08% | -5.06% | -5.39% | -5.73% |
| Treasury Stock & Other | 0.92% | -48.87% | 4.26% | -6.58% | -1.19% |
| Total Common Equity | -282.48% | -82.15% | -35.81% | -24.11% | 781.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -282.48% | -82.15% | -35.81% | -24.11% | 781.89% |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
| Total Minority Interest | -0.30% | -1.52% | -3.21% | -3.94% | -8.60% |
| Total Equity | -15.09% | 299.09% | -40.18% | -26.34% | 1,929.22% |
|
|
|||||